Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research

Part of paid clinical trials in Dallas, Texas.

Sponsor
Baylor Research Institute
Study ID
NCT04664192
Status
Recruiting
Apply to this trial

Conditions

  • Interstitial Lung Disease
  • Lung Diseases
  • Respiratory Failure

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Patient Biospecimen Registry (observational and blood sampling) — OTHER
    Clinical data collected at every blood sample collection visit.

Study Details

A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.

Key Dates

Start date
Jun 4, 2021
Status verified
Jan 2026
Primary completion
Jun 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Lung transplant Recipients
    Biobank registry for Lung transplant recipients

Primary Outcome Measure

Diagnosis of patients with lung transplant [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor Scott & White Research InstituteDallasTexas75246
Brianna Kamran
[email protected]
214-820-1685
Felicia Padilla, MPH
[email protected]
214-820-1771
Susan Mathai, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Dallas, TX

By research site
Baylor Scott & White Research Institute· Dallas, TX

Related Studies